X

Assurant Shares Change After Q4 Earnings Release

Assurant, Inc. (NYSE: AIZ) stock price reflected trading on the New York Stock Exchange, where Assurant’s shares have fluctuated around…

InvenTrust Properties Q4 FFO Rises, FY Profit Jumps; Shares Edge Lower Despite Strong Leasing, NOI Growth

Stock Reaction and Trading Context   InvenTrust Properties Corp. (NYSE: IVT) shares traded at $28.21, down modestly intraday following the…

Shopify Q4 2025 Earnings Results

Shopify today reported strong financial results for the fourth quarter and full year ended December 31, 2025, with significant revenue…

Earnings Summary: Highlights of T-Mobile’s (TMUS) Q4 2025 earnings report

Telecom giant T-Mobile US Inc. (NASDAQ: TMUS) announced financial results for the fourth quarter of fiscal 2025, reporting higher revenues…

Hilton Q4 2025 Earnings: Net Income Falls, But EBITDA Soars

Q4 Earnings Show Mixed Results   Hilton Worldwide Holdings Inc. (NYSE: HLT) released strong Q4 earnings. However, net income fell.…

Lucid Group: Gravity Launch Can’t Fix Broken Margins

Executive Summary Lucid Group, Inc. (LCID) remains a technology leader in the electric vehicle (EV) sector, distinguished by its superior…

Earnings Summary: Kraft Heinz’s Q4 2025 earnings decline on lower sales

The Kraft Heinz Company (NASDAQ: KHC), a food and beverage manufacturer, on Wednesday reported a decline in adjusted earnings and…

American International Group, Inc posts stronger FY25 earnings as underwriting income rises; Q4 profitability improves

American International Group, Inc. (NYSE: AIG) reported improved full-year 2025 earnings and stronger underwriting performance in the fourth quarter, supported…

O-I Glass, Inc. reports stronger full-year 2025 earnings as cost savings lift EPS and free cash flow

O-I Glass, Inc. (NYSE: OI) reported significantly stronger full-year and fourth-quarter 2025 results, supported by benefits from its “Fit to…

Gilead Sciences (GILD) Q4 2025 adj. earnings decline, despite higher revenues

Gilead Sciences, Inc. (NASDAQ: GILD), a research-based biopharmaceutical company, has reported a decline in adjusted earnings for the fourth quarter…